For example, Indium-111 radio-labeled anti-PSMA mAb (mAb 7E11) has been approved by Food and Drug Administration (FDA) for the radiographic test of PCa [30,32,33,34,35,36] Some mAbs-conjugated immunotoxins or nanoparticles as PCa-targeted agents have been tested in clinical trials [37,38,39,40,41,42,43,44,45,46,47,48,49]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.